Zacks Research slashed its Q1 2026 earnings estimate for Elevance Health from $12.30 to $11.96 per share. Analysts also ...

Health-care company stocks were among the few gainers in Wall Street Monday, after Health and Human Services Secretary Robert F. Kennedy Jr. expressed support for vaccines as a way to fight a measles ...

Special Needs Plans boosted a sluggish Medicare Advantage market during the annual enrollment period for 2025, a Modern ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Guardant Health (GH – Research Report), ...

Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...

A GOP budget plan that requires deep cuts to Medicaid spending battered shares of health insurers and hospitals that do big ...

Operating income fell for all but two major payers’ insurance divisions in the fourth quarter. And 2025 may be no better, ...

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...

For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.

Humana Inc. shares (HUM) slid 4.5%, CVS Health Corp.'s stock (CVS) gave up 1.7%, Centene Corp. shares (CNC) slid 1.5% and Elevance Health Inc.'s stock (ELV) was down 1.9%.